DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
International Symposium on Graves’ Orbitopathy
The EUGOGO 20th Anniversary Meeting programme will be submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME) and the Italian Educazione Continua in medicine (ECM) for Physician (Medico Chirurgo).
Certificate of Attendance can be collected at registration desk only at the end of the Meeting.
When:
November 7- 9, 2019
Where:
Camera di Commercio di Pisa
Piazza Vittorio Emanuele II, 5-56125
Pisa, Italy.
The event has ended.


Related Content
-
Videos & VisualsThyroid Eye Disease: The Battle of the Bulge, Part IIhttps://www.youtube.com/watch?v=S9H6V-sO...
-
Evidence & EducationEfficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
-
People & PlacesCasey Eye Institute – Thyroid Eye Disease CenterAs part of Oregon Health & Science U...
-
Evidence & EducationTEPEZZA (teprotumumab-trbw)- Frequently Asked Questions1. What is TEPEZZA? TEPEZZA is the firs...
-
News & MeetingsHorizon Therapeutics plc Reports Strong Third-Quarter 2019 ResultsHorizon Therapeutics plc today announced...
-
News & MeetingsHorizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
-
People & PlacesDavid B. Granet, MD, FAAO, FACS, FAAPDavid B. Granet is the Anne Ratner Chair...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.